Headed by
Nicolas Faguer,
McDermott Will & Schulte‘s practice is adept at representing investments funds, companies and individual shareholders in sensitive post-M&A litigation and shareholders’ conflicts, while also handling a diverse caseload that includes commercial litigation and industrial and product liability disputes. The team’s involvement spans various industries, most notably the healthcare sector, where it acts for several pharmaceutical laboratories in proceedings linked to the development of new drug products. Adrien Gros provides support.